Skip to main content
logo
Novavax, Inc. (NVAX)
NASDAQ: NVAX · Real-Time Price · USD
8.38
-0.04 (-0.48%)
Apr 9, 2026, 10:31 AM EDT - Market open

Novavax Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,123682.16983.711,9821,146
Revenue Growth (YoY)
64.69%-30.65%-50.37%72.89%141.02%
Cost of Revenue
73.04202.74343.77902.64-
Gross Profit
1,050479.42639.941,0791,146
Selling, General & Admin
157.48337.19468.95488.69298.36
Research & Development
342.32391.17737.51,2352,535
Other Operating Expenses
97.85----
Total Operating Expenses
597.64728.351,2061,7242,833
Operating Income
452.8-248.93-566.51-644.74-1,687
Interest Expense
-22.55-20.08-14.42-19.88-21.13
Other Non-Operating Income (Expense)
11.9292.3937.910.97-6.83
Total Non-Operating Income (Expense)
-10.6372.3223.48-8.91-27.96
Pretax Income
442.17-176.62-543.03-653.65-1,715
Provision for Income Taxes
-1.87-10.88-2.03-4.29-29.22
Net Income
440.3-187.5-545.06-657.94-1,744
Net Income to Common
440.3-187.5-545.06-657.94-1,744
Shares Outstanding (Basic)
1621521017874
Shares Outstanding (Diluted)
1731521017874
Shares Change (YoY)
13.74%51.03%28.89%5.08%29.27%
EPS (Basic)
2.72-1.23-5.41-8.42-23.44
EPS (Diluted)
2.58-1.23-5.41-8.42-23.44
Shares Outstanding
162.58160.42139.5186.0475.84
Free Cash Flow
-250.2-100.32-767.74-504.99268.45
Free Cash Flow Per Share
-1.45-0.66-7.62-6.463.61
Gross Margin
93.50%70.28%65.05%54.46%100.00%
Operating Margin
40.30%-36.49%-57.59%-32.53%-147.13%
Profit Margin
39.19%-27.49%-55.41%-33.20%-152.12%
FCF Margin
-22.27%-14.71%-78.05%-25.48%23.42%
EBITDA
480.41-200.44-525.29-615.68-1,674
EBITDA Margin
42.76%-29.38%-53.40%-31.07%-146.03%
EBIT
452.8-248.93-566.51-644.74-1,687
EBIT Margin
40.30%-36.49%-57.59%-32.53%-147.13%
Effective Tax Rate
-0.42%6.16%0.37%0.66%1.70%
Updated Feb 26, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q